← Leaderboards
Arun J Sanyal
Virginia Commonwealth University
$37,042,537
Attributed
$43,725,087
Total exposure
65
Grants
50
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$43,725,087 · 65
By mechanism
U01$18,512,985 · 6
R01$10,763,584 · 6
T32$4,247,940 · 1
KL2$3,714,720 · 1
M01$1,466,108 · 45
K24$1,205,965 · 1
Top collaborators
- Serge P Nana-Sinkam6 shared
- Jasmohan S Bajaj5 shared
- Edward A Dennis4 shared
- Mohammad S Siddiqui4 shared
- James A Tonascia4 shared
- Frederick Gerard Moeller2 shared
- Richard K. Sterling2 shared
- Juan Pablo Arab1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Richard K. Sterling$9,383,090
- Bin Gao$700,617
Others in their field
Top investigators on “Liver Diseases”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Larry Arthur$49,271,333
Research focus
Liver DiseasesFundingResearch PersonnelClinical ResearchClinical TrialsLiverUnited States National Institutes Of HealthBaseNonalcoholic SteatohepatitisGrantCirrhosisResourcesProspectiveRandomizedInnovationEnrollmentDisease ProgressionDatabasesNon-Alcoholic Fatty LiverPathogenesisFatty LiverSamplingInsightPlacebos
Grant awards (176)
Bile Acid-Mediated Signaling In HCC$573,697
P01 · FY2025 · CA · contact PI
Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis$534,392
R01 · FY2025 · DK · contact PI
Liver Cirrhosis Network: Clinical Research Centers$362,704
U01 · FY2025 · DK · contact PI
Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Virginia Commonwealth University$341,550
U01 · FY2025 · AA
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)$250,001
U01 · FY2025 · DK · contact PI
Bile Acid-Mediated Signaling In HCC$573,697
P01 · FY2024 · CA · contact PI
Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis$561,154
R01 · FY2024 · DK · contact PI
Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Virginia Commonwealth University$341,550
U01 · FY2024 · AA · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)$249,999
U01 · FY2024 · DK · contact PI
Liver Cirrhosis Network: Clinical Research Centers$213,145
U01 · FY2024 · DK · contact PI
CTSA K12 Program at Virginia Commonwealth University$749,462
K12 · FY2023 · TR
Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis$580,486
R01 · FY2023 · DK · contact PI
Liver Cirrhosis Network: Clinical Research Centers$306,200
U01 · FY2023 · DK · contact PI
Nonalcoholic Steatohepatittis Clinical Research Network (NASH CRN)$266,181
U01 · FY2023 · DK · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 9/9$116,733
U01 · FY2023 · AA
Institutional Career Development Core$742,944
KL2 · FY2022 · TR
Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis$634,480
R01 · FY2022 · DK · contact PI
Liver Cirrhosis Network: Clinical Research Centers$375,370
U01 · FY2022 · DK · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 9/9$352,539
U01 · FY2022 · AA
A PRECLINICAL MODEL OF ALCOHOLIC HEPATITIS$331,264
UH3 · FY2022 · AA · contact PI
Nonalcoholic Steatohepatittis Clinical Research Network (NASH CRN)$90,490
U01 · FY2022 · DK · contact PI
Novel Therapies for Alcoholic Hepatitis with Sepsis and for Relapse Prevention$63,088
U01 · FY2022 · AA · contact PI
Institutional Career Development Core$742,944
KL2 · FY2021 · TR
A PRECLINICAL MODEL OF ALCOHOLIC HEPATITIS$381,198
UH3 · FY2021 · AA · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 9/9$363,403
U01 · FY2021 · AA · contact PI
Liver Cirrhosis Network: Clinical Research Centers$358,454
U01 · FY2021 · DK · contact PI
Nonalcoholic Steatohepatittis Clinical Research Network (NASH CRN)$158,006
U01 · FY2021 · DK · contact PI
Novel Therapies for Alcoholic Hepatitis with Sepsis and for Relapse Prevention$63,088
U01 · FY2021 · AA · contact PI
Institutional Career Development Core$742,944
KL2 · FY2020 · TR
Nonalcoholic Steatohepatittis Clinical Research Network (NASH CRN)$515,091
U01 · FY2020 · DK · contact PI
A PRECLINICAL MODEL OF ALCOHOLIC HEPATITIS$376,540
UH3 · FY2020 · AA · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 9/9$363,403
U01 · FY2020 · AA · contact PI
Novel Therapies for Alcoholic Hepatitis with Sepsis and for Relapse Prevention$63,314
U01 · FY2020 · AA · contact PI
Institutional Career Development Core$742,944
KL2 · FY2019 · TR
Nonalcoholic Steatohepatittis Clinical Research Network (NASH CRN)$435,547
U01 · FY2019 · DK · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 9/9$363,403
U01 · FY2019 · AA · contact PI
A PRECLINICAL MODEL OF ALCOHOLIC HEPATITIS$193,355
UH2 · FY2019 · AA · contact PI
Novel Therapies for Alcoholic Hepatitis with Sepsis and for Relapse Prevention$74,378
U01 · FY2019 · AA · contact PI
Institutional Career Development Core$742,944
KL2 · FY2018 · TR
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS$681,226
R01 · FY2018 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)$422,434
U01 · FY2018 · DK · contact PI
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 9/9$353,547
U01 · FY2018 · AA · contact PI
A PRECLINICAL MODEL OF ALCOHOLIC HEPATITIS$262,347
UH2 · FY2018 · AA · contact PI
Novel Therapies for Alcoholic Hepatitis with Sepsis and for Relapse Prevention$74,941
U01 · FY2018 · AA · contact PI
Administrative Supplement to 1U01AA026979 (TREAT 02)$6,640
U01 · FY2018 · AA · contact PI
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS$685,245
R01 · FY2017 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)$454,145
U01 · FY2017 · DK · contact PI
Training Grant in Digestive Diseases and Liver Diseases$334,987
T32 · FY2017 · DK · contact PI
TREAT-VCU$195,013
U01 · FY2017 · AA · contact PI
Training Grant in Digestive Diseases and Liver Diseases$3,024
T32 · FY2017 · DK · contact PI
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS$692,611
R01 · FY2016 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)$610,824
U01 · FY2016 · DK · contact PI
TREAT-VCU$508,748
U01 · FY2016 · AA · contact PI
Training Grant in Digestive Diseases and Liver Diseases$296,567
T32 · FY2016 · DK · contact PI
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS$722,151
R01 · FY2015 · DK · contact PI
TREAT-VCU$497,828
U01 · FY2015 · AA · contact PI
Effect of Alcohol on Obesity Related Liver Disease$477,439
R01 · FY2015 · AA · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)$476,340
U01 · FY2015 · DK · contact PI
Training Grant in Digestive Diseases and Liver Diseases$300,596
T32 · FY2015 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)$83,412
U01 · FY2015 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)$585,501
U01 · FY2014 · DK · contact PI
TREAT-VCU$504,933
U01 · FY2014 · AA · contact PI
Effect of Alcohol on Obesity Related Liver Disease$481,606
R01 · FY2014 · AA · contact PI
Training Grant in Digestive Diseases and Liver Diseases$326,579
T32 · FY2014 · DK · contact PI
Effect of Alcohol on Obesity Related Liver Disease$463,796
R01 · FY2013 · AA · contact PI
TREAT-VCU$435,302
U01 · FY2013 · AA · contact PI
Training Grant in Digestive Diseases and Liver Diseases$313,939
T32 · FY2013 · DK · contact PI
Molecular Determinants of Disease Progression in Nonalcoholic Steatohepatitis$307,538
R01 · FY2013 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network$279,393
U01 · FY2013 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network$198,420
U01 · FY2013 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network$192,692
U01 · FY2013 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network$162,679
U01 · FY2013 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network$633,846
U01 · FY2012 · DK · contact PI
Effect of Alcohol on Obesity Related Liver Disease$500,984
R01 · FY2012 · AA · contact PI
TREAT-VCU$353,563
U01 · FY2012 · AA · contact PI
Molecular Determinants of Disease Progression in Nonalcoholic Steatohepatitis$318,692
R01 · FY2012 · DK · contact PI
Training Grant in Digestive Diseases and Liver Disease$298,530
T32 · FY2012 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network$534,941
U01 · FY2011 · DK · contact PI
Effect of Alcohol on Obesity Related Liver Disease$503,279
R01 · FY2011 · AA · contact PI
Molecular Determinants of Disease Progression in Nonalcoholic Steatohepatitis$318,692
R01 · FY2011 · DK · contact PI
Training Grant in Digestive Diseases and Liver Disease$313,391
T32 · FY2011 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network$600,900
U01 · FY2010 · DK · contact PI
Molecular Determinants of Disease Progression in Nonalcoholic Steatohepatitis$355,212
R01 · FY2010 · DK · contact PI
Training Grant in Digestive Diseases and Liver Disease$280,720
T32 · FY2010 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network$104,771
U01 · FY2010 · DK · contact PI
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$47,355
M01 · FY2010 · RR · contact PI
THE NATURAL HISTORY OF NONALCOHOLIC FATTY LIVER DISEASE$30,765
M01 · FY2010 · RR · contact PI
A STUDY OF THE ACTIVATION OF ENDOPLASMIC RETICULUM STRESS AND DIFFERENTIAL EX$21,744
M01 · FY2010 · RR · contact PI
A PHASE II TRIAL OF URSODEOXYCHOLIC ACID (UDCA) THERAPY FOR BILIARY$5,638
M01 · FY2010 · RR · contact PI
PIOGLITAZONE VS VITAMIN E VS PLACEBO NONDIAB, NASH$4,671
M01 · FY2010 · RR · contact PI
TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN CHILDREN (TONIC)$1,611
M01 · FY2010 · RR · contact PI
GENETICS OF PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE: PARENT STUDY (GOALS)$161
M01 · FY2010 · RR · contact PI
ACTIVATION OF THE ENDOGENOUS CANNABINOID SYSTEM IN NON-ALCOHOLIC FATTY LIVER$161
M01 · FY2010 · RR · contact PI
Hepatitis B Clinical Research Network$388,900
U01 · FY2009 · DK · contact PI
Molecular Determinants of Disease Progression in Nonalcoholic Steatohepatitis$358,800
R01 · FY2009 · DK · contact PI
Nonalcoholic Steatohepatitis Clinical Research Network$325,158
U01 · FY2009 · DK · contact PI
Training Grant in Digestive Diseases and Liver Disease$305,477
T32 · FY2009 · DK · contact PI
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$144,160
M01 · FY2009 · RR · contact PI
A STUDY OF THE ACTIVATION OF ENDOPLASMIC RETICULUM STRESS AND DIFFERENTIAL EX$95,640
M01 · FY2009 · RR · contact PI
PIOGLITAZONE VS VITAMIN E VS PLACEBO NONDIAB, NASH$79,778
M01 · FY2009 · RR · contact PI
THE NATURAL HISTORY OF NON-ALCOHOLIC FATTY LIVER DISEASE$69,981
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A PHASE II TRIAL OF URSODEOXYCHOLIC ACID (UDCA) THERAPY FOR BILI$18,195
M01 · FY2009 · RR · contact PI
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN (TONIC)$10,731
M01 · FY2009 · RR · contact PI
Training Grant in Digestive Diseases and Liver Disease$6,158
T32 · FY2009 · DK · contact PI
CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS$391,103
U01 · FY2008 · DK · contact PI
Training Grant in Digestive Diseases and Liver Disease$255,720
T32 · FY2008 · DK · contact PI
Studies of Mechanisms and Treatment of Liver Diseases$146,447
K24 · FY2008 · DK · contact PI
Hepatitis B Clinical Research Network$119,209
U01 · FY2008 · DK · contact PI
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$103,154
M01 · FY2008 · RR · contact PI
PIOGLITAZONE VS VITAMIN E VS PLACEBO NONDIAB, NASH$87,604
M01 · FY2008 · RR · contact PI
THE NATURAL HISTORY OF NONALCOHOLIC FATTY LIVER DISEASE$40,958
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: A PHASE II TRIAL OF URSODEOXYCHOLIC ACID (UDCA) THERAPY FOR BILI$12,515
M01 · FY2008 · RR · contact PI
TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN CHILDREN (TONIC)$12,136
M01 · FY2008 · RR · contact PI
ACTIVATION OF THE ENDOGENOUS CANNABINOID SYSTEM IN NON-ALCOHOLIC FATTY LIVER$10,618
M01 · FY2008 · RR · contact PI
CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS$641,103
U01 · FY2007 · DK · contact PI
Training Grant in Digestive Diseases and Liver Diseases$262,865
T32 · FY2007 · DK · contact PI
Biliary Microlithiasis in Alcohol Induced Pancreatitis$166,382
R21 · FY2007 · AA · contact PI
Studies of Mechanisms and Treatment of Liver Diseases$146,447
K24 · FY2007 · DK · contact PI
A PROSPECTIVE STUDY FOR THE NATURAL HISTORY OF CHRONIC PANCREATITIS$112,016
M01 · FY2007 · RR · contact PI
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$86,383
M01 · FY2007 · RR · contact PI
PIOGLITAZONE VS VITAMIN E VS PLACEBO NONDIAB, NASH$78,658
M01 · FY2007 · RR · contact PI
THE NATURAL HISTORY OF NONALCOHOLIC FATTY LIVER DISEASE$16,855
M01 · FY2007 · RR · contact PI
TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN CHILDREN (TONIC)$10,535
M01 · FY2007 · RR · contact PI
ACTIVATION OF THE ENDOGENOUS CANNABINOID SYSTEM IN NON-ALCOHOLIC FATTY LIVER$9,481
M01 · FY2007 · RR · contact PI
A PHASE II TRIAL OF URSODEOXYCHOLIC ACID (UDCA) THERAPY FOR BILIARY MICROLITHIA$5,618
M01 · FY2007 · RR · contact PI
SAFETY AND EFFICACY OF TACROLIMUS FOR THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS$1,756
M01 · FY2007 · RR · contact PI
ANGIOGRAPHY VS DOPPLER SONOGRAPHY TO PREVENT VARICEAL HEMORRHAGE$1,053
M01 · FY2007 · RR · contact PI
CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS$530,295
U01 · FY2006 · DK · contact PI
Biliary Microlithiasis in Alcohol Induced Pancreatitis$205,843
R21 · FY2006 · AA · contact PI
Studies of Mechanisms and Treatment of Liver Diseases$146,447
K24 · FY2006 · DK · contact PI
Training Grant in Digestive Diseases and Liver Diseases$84,236
T32 · FY2006 · DK · contact PI
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$68,611
M01 · FY2006 · RR · contact PI
THE NATURAL HISTORY OF NON-ALCOHOLIC FATTY LIVER DISEASE$24,346
M01 · FY2006 · RR · contact PI
PIOGLITAZONE VS VITAMIN E VS PLACEBO NONDIAB, NASH$14,861
M01 · FY2006 · RR · contact PI
SAFETY AND EFFICACY OF TACROLIMUS FOR THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS$11,067
M01 · FY2006 · RR · contact PI
ANGIOGRAPHY VS DOPPLER SONOGRAPHY TO PREVENT VARICEAL HEMORRHAGE$1,264
M01 · FY2006 · RR · contact PI
CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS$467,255
U01 · FY2005 · DK
Training Grant in Digestive Diseases and Liver Diseases$248,854
T32 · FY2005 · DK
Studies of Mechanisms and Treatment of Liver Diseases$146,447
K24 · FY2005 · DK
THE NATURAL HISTORY OF NONALCOHOLIC FATTY LIVER DISEASE$86,154
M01 · FY2005 · RR
SAFETY AND EFFICACY OF TACROLIMUS FOR THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS$32,308
M01 · FY2005 · RR
ANGIOGRAPHY VS DOPPLER SONOGRAPHY TO PREVENT VARICEAL HEMORRHAGE$8,169
M01 · FY2005 · RR
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE$4,085
M01 · FY2005 · RR
PIOGLITAZONE VS VITAMIN E VS PLACEBO NONDIAB, NASH$371
M01 · FY2005 · RR
CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS$464,108
U01 · FY2004 · DK
HEPATIC NEOVASCULARIZATION AND GENESIS OF TIPS STENOSIS$200,100
R01 · FY2004 · DK
Training Grant in Digestive Diseases and Liver Diseases$190,475
T32 · FY2004 · DK
CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS$149,000
U01 · FY2004 · DK
Studies of Mechanisms and Treatment of Liver Diseases$146,447
K24 · FY2004 · DK
The natural history of nonalcoholic fatty liver disease$53,347
M01 · FY2004 · RR
Tacrolimus for Treatment of Primary Biliary Cirrhosis$29,692
M01 · FY2004 · RR
Angiography vs Doppler Sonography to Prevent Variceal Hemorrhage$8,555
M01 · FY2004 · RR
Pioglitazone for the Tx of Nonalcoholic Steatohepatitis$755
M01 · FY2004 · RR
CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS$339,202
U01 · FY2003 · DK
HEPATIC NEOVASCULARIZATION AND GENESIS OF TIPS STENOSIS$200,100
R01 · FY2003 · DK
STUDIES OF MECHANISMS AND TREATMENT OF LIVER DISEASE$122,525
K24 · FY2003 · DK
Training Grant in Digestive Diseases and Liver Diseases$65,897
T32 · FY2003 · DK
CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS$339,202
U01 · FY2002 · DK
HEPATIC NEOVASCULARIZATION AND GENESIS OF TIPS STENOSIS$200,100
R01 · FY2002 · DK
STUDIES OF MECHANISMS AND TREATMENT OF LIVER DISEASE$119,743
K24 · FY2002 · DK
TRAINING GRANT IN DIGESTIVE AND LIVER DISEASES$62,330
T32 · FY2002 · DK
HEPATIC NEOVASCULARIZATION AND GENESIS OF TIPS STENOSIS$200,100
R01 · FY2001 · DK
STUDIES OF MECHANISMS AND TREATMENT OF LIVER DISEASE$117,042
K24 · FY2001 · DK
TRAINING GRANT IN DIGESTIVE AND LIVER DISEASES$74,968
T32 · FY2001 · DK
VPA 985 DOSING OF PATIENTS W/ HYPONATREMIA$0
M01 · FY2001 · RR
INSULIN RESISTANCE IN PATHOGENESIS OF NON ALCOHOLIC STEATOHEPATITIS$0
M01 · FY2001 · RR
RANDOMIZED CONTROLLED TRIAL OF ANGIOGRAPHY ALONE VS DOPPLER SONOGRPHY$0
M01 · FY2001 · RR
TRANSJUGULAR PORTASYSTEMIC SHUNTS/PARACENTESIS FOR TREATMENT OF ASCITES$0
M01 · FY2001 · RR
STUDY FOR THE TREATMENT OF REFRACTORY ASCITES$585,301
R01 · FY2000 · DK
TRAINING GRANT IN DIGESTIVE AND LIVER DISEASES$222,627
T32 · FY2000 · DK
HEPATIC NEOVASCULARIZATION AND GENESIS OF TIPS STENOSIS$200,100
R01 · FY2000 · DK
STUDIES OF MECHANISMS AND TREATMENT OF LIVER DISEASE$114,420
K24 · FY2000 · DK
TRANSJUGULAR PORTASYSTEMIC SHUNTS/PARACENTESIS FOR TREATMENT OF ASCITES$648
M01 · FY2000 · RR
VPA 985 DOSING OF PATIENTS W/ HYPONATREMIA$648
M01 · FY2000 · RR
INSULIN RESISTANCE IN PATHOGENESIS OF NON ALCOHOLIC STEATOHEPATITIS$648
M01 · FY2000 · RR
RANDOMIZED CONTROLLED TRIAL OF ANGIOGRAPHY ALONE VS DOPPLER SONOGRPHY$648
M01 · FY2000 · RR